World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
89
Citations
36873
World Ranking
1102
National Ranking
588

Medicine

D-Index
92
Citations
38248
World Ranking
11153
National Ranking
5736

Research.com Recognitions

  • 2012 - Alexander Fleming Award, Infectious Diseases Society of America
  • 2008 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 2001 - The Walter E. Stamm Mentor Award, Infectious Diseases Society of America

Overview

Martin S. Hirsch is affiliated with Harvard Medical School in the United States, specializing in the field of medicine with a focus on reproductive medicine and obstetrics and gynecology. Their work spans several subfields including public health, environmental and occupational health, general health professions, and sociology and political science.

Research topics frequently addressed by Hirsch include:

  • Endometriosis Research and Treatment
  • Uterine Myomas and Treatments
  • Pregnancy-related medical research
  • Delphi Technique in Research
  • Long-Term Effects of COVID-19
  • Maternal Mental Health During Pregnancy and Postpartum
  • Endometrial and Cervical Cancer Treatments

Hirsch has contributed to the academic community through publications in a number of journals, with frequent appearances in the following venues:

  • BJOG An International Journal of Obstetrics & Gynaecology
  • Facts Views and Vision in ObGyn
  • Fertility and Sterility
  • Current Opinion in Obstetrics & Gynecology
  • Human Reproduction

Some notable recent papers include:

  • "A core outcome set for future endometriosis research: an international consensus development study," 2020, BJOG An International Journal of Obstetrics & Gynaecology
  • "Antiretroviral Treatment of Adult HIV Infection 2008 Recommendations of the International AIDS Society-USA Panel," 2020, UNC Libraries
  • "The Prevalence of Endometriosis in Adolescents with Pelvic Pain: A Systematic Review," 2020, Journal of Pediatric and Adolescent Gynecology
  • "Developing a core outcome set for future infertility research: an international consensus development study," 2020, Human Reproduction
  • "Standardizing definitions and reporting guidelines for the infertility core outcome set: an international consensus development study," 2020, Human Reproduction

Frequent co-authors working with Hirsch include:

  • James MN Duffy
  • Cindy Farquhar
  • Ertan Sarıdoğan
  • M. Louise Hull
  • Siladitya Bhattacharya

During their career, Hirsch has received several awards, reflecting recognition in their field, including:

  • Alexander Fleming Award, Infectious Diseases Society of America, 2012
  • Fellow of the American Association for the Advancement of Science (AAAS), 2008
  • The Walter E. Stamm Mentor Award, Infectious Diseases Society of America, 2001

Best Publications

  • A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

    Scott M. Hammer;David A. Katzenstein;Michael D. Hughes;Holly Gundacker

  • Antiretroviral Therapy in Adults: Updated Recommendations of the International AIDS Society–USA Panel

    Charles C. J. Carpenter;David A. Cooper;Margaret A. Fischl;Jose M. Gatell

  • Treatment for adult HIV infection : 2006 recommendations of the international AIDS society-USA panel

    Scott M. Hammer;Michael S. Saag;Mauro Schechter;Julio S. G. Montaner

  • HIV-specific cytotoxic T lymphocytes in seropositive individuals.

    Bruce D. Walker;Sekhar Chakrabarti;Bernard Moss;Timothy J. Paradis

  • Antiretroviral Therapy for HIV Infection in 1997: Updated Recommendations of the International AIDS Society—USA Panel

    Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch

  • Antiretroviral Treatment for Adult HIV Infection in 2002: Updated Recommendations of the International AIDS Society-USA Panel

    Patrick G. Yeni;Scott M. Hammer;Charles C. J. Carpenter;David A. Cooper

  • Antiretroviral Therapy for HIV Infection in 1998: Updated Recommendations of the International AIDS Society–USA Panel

    Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch

  • Infection of monocyte/macrophages by human T lymphotropic virus type III.

    David D. Ho;Teresa R. Rota;Martin S. Hirsch

  • Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an international AIDS society-USA panel

    Martin S. Hirsch;Françoise Brun-Vézinet;Richard T. D'Aquila;Scott M. Hammer

  • Herpes simplex encephalitis: vidarabine therapy and diagnostic problems.

    Richard J. Whitley;Seng-Jaw Soong;Martin S. Hirsch;Adolf W. Karchmer

  • Antiretroviral Treatment of Adult HIV Infection

    Scott M. Hammer;Joseph J. Eron;Peter Reiss;Robert T. Schooley

  • Antiretroviral therapy for HIV infection in 1996 : Recommendations of an international panel

    Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch

  • Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

    Patrick G. Yeni;Scott M. Hammer;Martin S. Hirsch;Michael S. Saag

  • Treatment for adult HIV infection.

    Yeni Pg;Hammer Sm;Hirsch Ms;Saag Ms

  • Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.

    Martin S. Hirsch;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  • Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel

    Martin S. Hirsch;Huldrych F. Günthard;Jonathan M. Schapiro;Francoise Brun-Vezinet

  • Music as an aid for postoperative recovery in adults: a systematic review and meta-analysis

    Jenny Hole;Martin Hirsch;Elizabeth Ball;Catherine Meads

  • HIV infection is blocked in vitro by recombinant soluble CD4

    Richard A. Fisher;Jeanne M. Bertonis;Werner Meier;Victoria A. Johnson

  • The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter

    David A. Katzenstein;Scott M. Hammer;Michael D. Hughes;Holly Gundacker

  • Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS.

    Dana H. Gabuzda;David D. Ho;Suzanne M. de la Monte;Martin S. Hirsch

  • Primary Human T-Lymphotropic Virus Type III Infection

    David D. Ho;M. G. Sarngadharan;Lionel Resnick;Fulvia Dimarzoveronese

  • Prevalence and predictive value of intermittent viremia with combination hiv therapy.

    Diane V. Havlir;Roland Bassett;Diane Levitan;Peter Gilbert

  • Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection

    Gregory K. Robbins;Victor De Gruttola;Robert W. Shafer;Laura M. Smeaton

  • HTLV-III in the semen and blood of a healthy homosexual man.

    David D. Ho;Robert T. Schooley;Teresa R. Rota;Joan C. Kaplan

  • HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals

    Bruce D. Walker;Charles Flexner;Timothy J. Paradis;Thomas C. Fuller

  • Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus.

    Paul R. Skolnik;Barry R. Kosloff;Martin S. Hirsch

Frequent Co-Authors

Robert T. Schooley
Robert T. Schooley University of California, San Diego
Douglas D. Richman
Douglas D. Richman University of California, San Diego
Margaret A. Fischl
Margaret A. Fischl University of Miami
Victoria A. Johnson
Victoria A. Johnson University of Alabama at Birmingham
Scott M. Hammer
Scott M. Hammer Columbia University
Richard T. D'Aquila
Richard T. D'Aquila Northwestern University
Thomas C. Merigan
Thomas C. Merigan Stanford University
José W. F. Valle
José W. F. Valle University of Valencia
Ting-Chao Chou
Ting-Chao Chou Memorial Sloan Kettering Cancer Center
Stefano Vella
Stefano Vella Istituto Superiore di Sanità

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, expanding into related healthcare fields can open diverse career opportunities. Many graduates choose to supplement their knowledge with nursing programs tailored to various experience levels, enhancing their qualifications and mobility in the medical sector.

Those with prior healthcare experience may consider accelerated nurse practitioner programs, designed to fast-track advanced practice nursing degrees. These programs combine clinical skills and patient care knowledge vital for immunology-related specialties.

Meanwhile, individuals new to healthcare can explore online nursing programs for non nurses. These programs provide foundational training without requiring prior nursing credentials, making healthcare careers more accessible.

For those seeking more straightforward admission, there are options like the easiest accelerated nursing programs which focus on fast admissions and expedited coursework. Similarly, lpn programs with easiest admission requirements offer entry points into practical nursing roles that complement immunology-related professions.

Choosing the right program depends on your background, goals, and the time you can commit. Exploring these pathways can enhance your career flexibility while building on your immunology foundation.

Best Scientists Citing Martin S. Hirsch

Trending Scientists